Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$304.11 - $351.99 $4.74 Million - $5.49 Million
-15,597 Reduced 93.64%
1,060 $366,000
Q4 2023

Feb 14, 2024

SELL
$269.37 - $365.04 $4.87 Million - $6.6 Million
-18,070 Reduced 52.03%
16,657 $5.38 Million
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $3.26 Million - $3.94 Million
-9,319 Reduced 21.16%
34,727 $12.4 Million
Q2 2023

Nov 13, 2023

BUY
$359.49 - $486.4 $1.05 Million - $1.42 Million
2,919 Added 7.1%
44,046 $16.7 Million
Q1 2023

Nov 13, 2023

SELL
$418.69 - $503.0 $11.9 Million - $14.3 Million
-28,350 Reduced 40.8%
41,127 $19.7 Million
Q1 2023

May 02, 2023

SELL
$418.69 - $503.0 $7.48 Million - $8.99 Million
-17,866 Reduced 25.71%
51,611 $24.7 Million
Q4 2022

Nov 13, 2023

BUY
$351.71 - $456.01 $6.28 Million - $8.15 Million
17,866 Added 34.62%
69,477 $29.2 Million
Q4 2022

Feb 10, 2023

BUY
$351.71 - $456.01 $5.77 Million - $7.49 Million
16,419 Added 30.95%
69,477 $29.2 Million
Q3 2022

Nov 09, 2022

BUY
$412.59 - $563.26 $1.49 Million - $2.03 Million
3,601 Added 7.28%
53,058 $22.1 Million
Q2 2022

Aug 10, 2022

BUY
$463.67 - $597.16 $6.34 Million - $8.17 Million
13,678 Added 38.23%
49,457 $24.5 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $17.8 Million - $24.9 Million
33,907 Added 1811.27%
35,779 $20.2 Million
Q4 2021

Feb 08, 2022

BUY
$708.84 - $794.68 $22,682 - $25,429
32 Added 1.74%
1,872 $1.41 Million
Q2 2021

Jul 27, 2021

BUY
$576.64 - $649.04 $1.06 Million - $1.19 Million
1,840 New
1,840 $1.19 Million
Q2 2021

Jul 26, 2021

SELL
$576.64 - $649.04 $1.06 Million - $1.19 Million
-1,840 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $724,144 - $912,412
-1,418 Reduced 43.52%
1,840 $1.07 Million
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $4,089 - $4,820
-9 Reduced 0.28%
3,258 $1.68 Million
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $34.5 Million - $50.9 Million
-103,146 Reduced 96.93%
3,267 $1.48 Million
Q1 2020

May 13, 2020

SELL
$320.01 - $409.07 $18.5 Million - $23.6 Million
-57,745 Reduced 35.18%
106,413 $37.3 Million
Q4 2019

Feb 11, 2020

SELL
$319.73 - $374.2 $34.8 Million - $40.8 Million
-108,996 Reduced 39.9%
164,158 $60.7 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $112 Million - $127 Million
-368,654 Reduced 57.44%
273,154 $90.9 Million
Q2 2019

Aug 13, 2019

BUY
$286.93 - $312.59 $15.8 Million - $17.3 Million
55,191 Added 9.41%
641,808 $201 Million
Q1 2019

May 13, 2019

BUY
$224.3 - $317.41 $132 Million - $186 Million
586,617 New
586,617 $179 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.42B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Easterly Investment Partners LLC Portfolio

Follow Easterly Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.